Cargando…
A Novel Tumor Suppressor SPINK5 Serves as an Independent Prognostic Predictor for Patients with Head and Neck Squamous Cell Carcinoma
BACKGROUND: In our previous study, serine protease inhibitor Kazal-type 5 (SPINK5), which encodes the product of serine protease inhibitor lymphoepithelial Kazal-type-related inhibitor (LEKTI) was found to be down-regulated in head and neck squamous cell carcinoma (HNSCC) using oligonucleotide micro...
Autores principales: | Lv, Zhongjing, Wu, Kun, Qin, Xing, Yuan, Jian, Yan, Ming, Zhang, Jianjun, Wang, Lizhen, Ji, Tong, Cao, Wei, Chen, Wantao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320891/ https://www.ncbi.nlm.nih.gov/pubmed/32606974 http://dx.doi.org/10.2147/CMAR.S236266 |
Ejemplares similares
-
TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer
por: Wu, Xiangbing, et al.
Publicado: (2013) -
Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma
por: Lv, Zhongjing, et al.
Publicado: (2014) -
TGFβ3-mediated induction of Periostin facilitates head and neck cancer growth and is associated with metastasis
por: Qin, Xing, et al.
Publicado: (2016) -
TP53-Associated Ion Channel Genes Serve as Prognostic Predictor and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma
por: Sun, Jing, et al.
Publicado: (2020) -
CD147 promotes progression of head and neck squamous cell carcinoma via NF‐kappa B signaling
por: Yu, Binbin, et al.
Publicado: (2018)